Track PURE Bioscience's current cash ($980K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (April 2026), PURE shows a current cash of $980K. That compares with $540K in the prior-year period — up 82.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PURE's current cash is now $980K (was $540K) — a 82.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether PURE Bioscience is outperforming or lagging.
Tracking PURE's current cash over time shows whether PURE Bioscience is scaling, shrinking, or reshaping that part of the business. The current reading is $980K That compares with $540K in the prior-year period — up 82.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has PURE Bioscience's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $980K) with ownership activity and broader fundamentals.